OXALTIN 50 MG

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

OXALIPLATIN 50 MG

Disponibbli minn:

PERRIGO ISRAEL AGENCIES LTD

Kodiċi ATC:

L01XA03

Għamla farmaċewtika:

POWDER FOR SOLUTION FOR INFUSION

Rotta amministrattiva:

I.V

Manifatturat minn:

ACTAVIS ITALY S.P.A

Grupp terapewtiku:

OXALIPLATIN

Indikazzjonijiet terapewtiċi:

Oxaliplatin in combination with 5-fluorouracil (5-FU) and folinic acid (FA) is indicated for:- Adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumour.-Treatment of metastatic colorectal cancer.

Data ta 'l-awtorizzazzjoni:

2013-08-01